Older peoples’ views on cardiovascular disease medication: a qualitative study
journal contribution
posted on 2022-08-02, 01:16authored byKatharine A Wallis, Denise TaylorDenise Taylor, Elizabeth F Fanueli, Priya Saravanakumar, Susan Wells
Abstract
Background
There is increasing evidence for the potential benefits and harms of cardiovascular disease (CVD) medications in older people (>75 years) prompting updating of clinical guidelines. We explored the views of older people about CVD medication to inform guideline development.
Methods
Qualitative study using semistructured interviews and focus groups. An ethnically diverse group of community dwelling older people were purposefully recruited from northern New Zealand using flyers in primary care clinics, local libraries, social groups, and places of worship, and by word of mouth. Interviews and focus groups were digitally recorded, transcribed verbatim, and analysed using an iterative and inductive approach to thematic analysis.
Results
Thirty-nine participants from 4 ethnic groups were recruited (mean 74 years; range 61–91 years; Māori (7), South Asian (8), European (9), and Pasifika (15)). Most participants were taking CVD medication/s. Four main themes emerged: (i) emphasizing the benefits of CVD medication and downplaying the harms; (ii) feeling compelled to take medication; (iii) trusting “my” doctor; and (iv) expecting medication to be continued.
Conclusion
Findings raise questions about older people’s agency in decision-making regarding CVD medication. CVD risk management guidelines for older people could include strategies to support effective communication of the potential benefits and harms of CVD medication in older people, balancing life expectancy, and the expected duration of therapy.
History
Preferred citation
Wallis, K. A., Taylor, D. A., Fanueli, E. F., Saravanakumar, P. & Wells, S. (2022). Older peoples’ views on cardiovascular disease medication: a qualitative study. Family Practice. https://doi.org/10.1093/fampra/cmab186